3.26.1 html 146 289 1 false 55 0 false 8 false false R1.htm 0000001 - Document - Cover Sheet http://www.acumenpharm.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - Condensed Balance Sheets Sheet http://www.acumenpharm.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 9952152 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.acumenpharm.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - Condensed Statements of Operations and Comprehensive Loss Sheet http://www.acumenpharm.com/role/CondensedStatementsofOperationsandComprehensiveLoss Condensed Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 9952154 - Statement - Condensed Statements of Changes in Stockholders??? Equity Sheet http://www.acumenpharm.com/role/CondensedStatementsofChangesinStockholdersEquity Condensed Statements of Changes in Stockholders??? Equity Statements 5 false false R6.htm 9952155 - Statement - Condensed Statements of Changes in Stockholders??? Equity (Parenthetical) Sheet http://www.acumenpharm.com/role/CondensedStatementsofChangesinStockholdersEquityParenthetical Condensed Statements of Changes in Stockholders??? Equity (Parenthetical) Statements 6 false false R7.htm 9952156 - Statement - Condensed Statements of Cash Flows Sheet http://www.acumenpharm.com/role/CondensedStatementsofCashFlows Condensed Statements of Cash Flows Statements 7 false false R8.htm 9952157 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Sheet http://www.acumenpharm.com/role/DESCRIPTIONOFORGANIZATIONANDBUSINESSOPERATIONS DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Notes 8 false false R9.htm 9952158 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 9952159 - Disclosure - MARKETABLE SECURITIES Sheet http://www.acumenpharm.com/role/MARKETABLESECURITIES MARKETABLE SECURITIES Notes 10 false false R11.htm 9952160 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 11 false false R12.htm 9952161 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Sheet http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATION SUPPLEMENTAL FINANCIAL INFORMATION Notes 12 false false R13.htm 9952162 - Disclosure - DEBT Sheet http://www.acumenpharm.com/role/DEBT DEBT Notes 13 false false R14.htm 9952163 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://www.acumenpharm.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS??? EQUITY Notes 14 false false R15.htm 9952164 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.acumenpharm.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 15 false false R16.htm 9952165 - Disclosure - SEGMENT REPORTING Sheet http://www.acumenpharm.com/role/SEGMENTREPORTING SEGMENT REPORTING Notes 16 false false R17.htm 9952166 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.acumenpharm.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 18 false false R19.htm 9955511 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 19 false false R20.htm 9955512 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 20 false false R21.htm 9955513 - Disclosure - MARKETABLE SECURITIES (Tables) Sheet http://www.acumenpharm.com/role/MARKETABLESECURITIESTables MARKETABLE SECURITIES (Tables) Tables http://www.acumenpharm.com/role/MARKETABLESECURITIES 21 false false R22.htm 9955514 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTS 22 false false R23.htm 9955515 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables) Sheet http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables SUPPLEMENTAL FINANCIAL INFORMATION (Tables) Tables http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATION 23 false false R24.htm 9955516 - Disclosure - DEBT (Tables) Sheet http://www.acumenpharm.com/role/DEBTTables DEBT (Tables) Tables http://www.acumenpharm.com/role/DEBT 24 false false R25.htm 9955517 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.acumenpharm.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.acumenpharm.com/role/STOCKBASEDCOMPENSATION 25 false false R26.htm 9955518 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://www.acumenpharm.com/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://www.acumenpharm.com/role/SEGMENTREPORTING 26 false false R27.htm 9955519 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) Sheet http://www.acumenpharm.com/role/DESCRIPTIONOFORGANIZATIONANDBUSINESSOPERATIONSDetails DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) Details http://www.acumenpharm.com/role/DESCRIPTIONOFORGANIZATIONANDBUSINESSOPERATIONS 27 false false R28.htm 9955520 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Sheet http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Details 28 false false R29.htm 9955521 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) Details 29 false false R30.htm 9955522 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share (Details) Sheet http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofLossPerShareDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share (Details) Details 30 false false R31.htm 9955523 - Disclosure - MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) Sheet http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) Details 31 false false R32.htm 9955524 - Disclosure - MARKETABLE SECURITIES - Schedule of Unrealized Loss on Investments (Details) Sheet http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails MARKETABLE SECURITIES - Schedule of Unrealized Loss on Investments (Details) Details 32 false false R33.htm 9955525 - Disclosure - MARKETABLE SECURITIES - Additional Information (Details) Sheet http://www.acumenpharm.com/role/MARKETABLESECURITIESAdditionalInformationDetails MARKETABLE SECURITIES - Additional Information (Details) Details 33 false false R34.htm 9955526 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Details 34 false false R35.htm 9955527 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of the Fair Value using Level 3 Significant Unobservable Inputs (Details) Sheet http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSScheduleoftheFairValueusingLevel3SignificantUnobservableInputsDetails FAIR VALUE MEASUREMENTS - Schedule of the Fair Value using Level 3 Significant Unobservable Inputs (Details) Details 35 false false R36.htm 9955528 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Prepaid Expenses and Other Current Assets (Details) Sheet http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Prepaid Expenses and Other Current Assets (Details) Details 36 false false R37.htm 9955529 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Accrued Expenses and Other Current Liabilities (Details) Details 37 false false R38.htm 9955530 - Disclosure - DEBT - Additional Information (Details) Sheet http://www.acumenpharm.com/role/DEBTAdditionalInformationDetails DEBT - Additional Information (Details) Details 38 false false R39.htm 9955531 - Disclosure - DEBT - Schedule of Outstanding Debt (Details) Sheet http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails DEBT - Schedule of Outstanding Debt (Details) Details 39 false false R40.htm 9955532 - Disclosure - DEBT - Schedule of Interest Expense, Debt (Details) Sheet http://www.acumenpharm.com/role/DEBTScheduleofInterestExpenseDebtDetails DEBT - Schedule of Interest Expense, Debt (Details) Details 40 false false R41.htm 9955533 - Disclosure - DEBT - Schedule of Aggregate Principal Payments (Details) Sheet http://www.acumenpharm.com/role/DEBTScheduleofAggregatePrincipalPaymentsDetails DEBT - Schedule of Aggregate Principal Payments (Details) Details 41 false false R42.htm 9955534 - Disclosure - STOCKHOLDERS??? EQUITY (Details) Sheet http://www.acumenpharm.com/role/STOCKHOLDERSEQUITYDetails STOCKHOLDERS??? EQUITY (Details) Details http://www.acumenpharm.com/role/STOCKHOLDERSEQUITY 42 false false R43.htm 9955535 - Disclosure - STOCK-BASED COMPENSATION - Additional Information (Details) Sheet http://www.acumenpharm.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails STOCK-BASED COMPENSATION - Additional Information (Details) Details 43 false false R44.htm 9955536 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Share-Based Compensation Expense Related to Stock Options (Details) Sheet http://www.acumenpharm.com/role/STOCKBASEDCOMPENSATIONScheduleofShareBasedCompensationExpenseRelatedtoStockOptionsDetails STOCK-BASED COMPENSATION - Schedule of Share-Based Compensation Expense Related to Stock Options (Details) Details 44 false false R45.htm 9955537 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Assumptions Used for Valuation of Fair Value of Stock Options (Details) Sheet http://www.acumenpharm.com/role/STOCKBASEDCOMPENSATIONScheduleofAssumptionsUsedforValuationofFairValueofStockOptionsDetails STOCK-BASED COMPENSATION - Schedule of Assumptions Used for Valuation of Fair Value of Stock Options (Details) Details 45 false false R46.htm 9955538 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details) Sheet http://www.acumenpharm.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details) Details 46 false false R47.htm 9955539 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Nonvested Restricted Stock Units Activity (Details) Sheet http://www.acumenpharm.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedRestrictedStockUnitsActivityDetails STOCK-BASED COMPENSATION - Schedule of Nonvested Restricted Stock Units Activity (Details) Details 47 false false R48.htm 9955540 - Disclosure - SEGMENT REPORTING - Additional Information (Details) Sheet http://www.acumenpharm.com/role/SEGMENTREPORTINGAdditionalInformationDetails SEGMENT REPORTING - Additional Information (Details) Details 48 false false R49.htm 9955541 - Disclosure - SEGMENT REPORTING - Schedule of Segment Reporting Information (Details) Sheet http://www.acumenpharm.com/role/SEGMENTREPORTINGScheduleofSegmentReportingInformationDetails SEGMENT REPORTING - Schedule of Segment Reporting Information (Details) Details 49 false false R50.htm 9955542 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.acumenpharm.com/role/COMMITMENTSANDCONTINGENCIESDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.acumenpharm.com/role/COMMITMENTSANDCONTINGENCIES 50 false false All Reports Book All Reports abos-20260331.htm abos-20260331.xsd abos-20260331_cal.xml abos-20260331_def.xml abos-20260331_lab.xml abos-20260331_pre.xml http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true